Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Graft vs Host Disease

1-methyl-3-isobutylxanthine has been researched along with Graft vs Host Disease in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Shaughnessy, MJ1
Chen, ZM1
Gramaglia, I1
Taylor, PA1
Panoskaltsis-Mortari, A1
Vogtenhuber, C1
Palmer, E1
Grader-Beck, T1
Boussiotis, VA1
Blazar, BR1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Graft vs Host Disease

ArticleYear
Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2007, Volume: 13, Issue:5

    Topics: 1-Methyl-3-isobutylxanthine; Animals; CD4-Positive T-Lymphocytes; Cell Transplantation; Cyclic AMP;

2007